Logo image of RDC.DE

REDCARE PHARMACY NV (RDC.DE) Stock Fundamental Analysis

FRA:RDC - Deutsche Boerse Ag - NL0012044747 - Common Stock - Currency: EUR

96.25  -1.4 (-1.43%)

Fundamental Rating

3

Taking everything into account, RDC scores 3 out of 10 in our fundamental rating. RDC was compared to 25 industry peers in the Consumer Staples Distribution & Retail industry. The financial health of RDC is average, but there are quite some concerns on its profitability. RDC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year RDC has reported negative net income.
In the past year RDC had a positive cash flow from operations.
RDC had negative earnings in each of the past 5 years.
RDC had a positive operating cash flow in 4 of the past 5 years.
RDC.DE Yearly Net Income VS EBIT VS OCF VS FCFRDC.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

RDC's Return On Assets of -4.74% is on the low side compared to the rest of the industry. RDC is outperformed by 80.00% of its industry peers.
With a Return On Equity value of -10.23%, RDC is not doing good in the industry: 76.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -4.74%
ROE -10.23%
ROIC N/A
ROA(3y)-5.45%
ROA(5y)-5.79%
ROE(3y)-11.19%
ROE(5y)-11.08%
ROIC(3y)N/A
ROIC(5y)N/A
RDC.DE Yearly ROA, ROE, ROICRDC.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

The Gross Margin of RDC (23.03%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of RDC has grown nicely.
The Profit Margin and Operating Margin are not available for RDC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.88%
GM growth 5Y3.23%
RDC.DE Yearly Profit, Operating, Gross MarginsRDC.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

More info and screens

5

2. Health

2.1 Basic Checks

RDC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RDC has less shares outstanding
Compared to 5 years ago, RDC has more shares outstanding
The debt/assets ratio for RDC is higher compared to a year ago.
RDC.DE Yearly Shares OutstandingRDC.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
RDC.DE Yearly Total Debt VS Total AssetsRDC.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 4.42 indicates that RDC is not in any danger for bankruptcy at the moment.
RDC has a Altman-Z score of 4.42. This is in the better half of the industry: RDC outperforms 76.00% of its industry peers.
A Debt/Equity ratio of 0.50 indicates that RDC is somewhat dependend on debt financing.
RDC has a Debt to Equity ratio of 0.50. This is in the better half of the industry: RDC outperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Altman-Z 4.42
ROIC/WACCN/A
WACC6.87%
RDC.DE Yearly LT Debt VS Equity VS FCFRDC.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

RDC has a Current Ratio of 1.80. This is a normal value and indicates that RDC is financially healthy and should not expect problems in meeting its short term obligations.
RDC has a Current ratio of 1.80. This is amongst the best in the industry. RDC outperforms 92.00% of its industry peers.
A Quick Ratio of 1.23 indicates that RDC should not have too much problems paying its short term obligations.
RDC's Quick ratio of 1.23 is amongst the best of the industry. RDC outperforms 96.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.23
RDC.DE Yearly Current Assets VS Current LiabilitesRDC.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

6

3. Growth

3.1 Past

RDC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -289.52%.
The Revenue has grown by 27.21% in the past year. This is a very strong growth!
RDC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.59% yearly.
EPS 1Y (TTM)-289.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-32.61%
Revenue 1Y (TTM)27.21%
Revenue growth 3Y30.76%
Revenue growth 5Y27.59%
Sales Q2Q%28.04%

3.2 Future

The Earnings Per Share is expected to grow by 53.17% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 18.25% on average over the next years. This is quite good.
EPS Next Y42.87%
EPS Next 2Y65.3%
EPS Next 3Y56.58%
EPS Next 5Y53.17%
Revenue Next Year25.45%
Revenue Next 2Y23.21%
Revenue Next 3Y21.76%
Revenue Next 5Y18.25%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
RDC.DE Yearly Revenue VS EstimatesRDC.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
RDC.DE Yearly EPS VS EstimatesRDC.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

RDC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 68.22, RDC can be considered very expensive at the moment.
92.00% of the companies in the same industry are cheaper than RDC, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.21, RDC is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 68.22
RDC.DE Price Earnings VS Forward Price EarningsRDC.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

80.00% of the companies in the same industry are cheaper than RDC, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 72.19
RDC.DE Per share dataRDC.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
RDC's earnings are expected to grow with 56.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y65.3%
EPS Next 3Y56.58%

More info and screens

0

5. Dividend

5.1 Amount

RDC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REDCARE PHARMACY NV

FRA:RDC (8/1/2025, 7:00:00 PM)

96.25

-1.4 (-1.43%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)07-29 2025-07-29
Inst Owners42.04%
Inst Owner ChangeN/A
Ins Owners7.4%
Ins Owner ChangeN/A
Market Cap1.98B
Analysts77.65
Price Target168.39 (74.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.93%
Min EPS beat(2)-42.68%
Max EPS beat(2)26.81%
EPS beat(4)2
Avg EPS beat(4)-32.13%
Min EPS beat(4)-159.9%
Max EPS beat(4)47.26%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.51%
Min Revenue beat(2)-2.24%
Max Revenue beat(2)-0.77%
Revenue beat(4)1
Avg Revenue beat(4)10.78%
Min Revenue beat(4)-2.24%
Max Revenue beat(4)47.4%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.39%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)0.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 68.22
P/S 0.78
P/FCF N/A
P/OCF 51.95
P/B 4.18
P/tB 29.7
EV/EBITDA 72.19
EPS(TTM)-2.41
EYN/A
EPS(NY)1.41
Fwd EY1.47%
FCF(TTM)-0.72
FCFYN/A
OCF(TTM)1.85
OCFY1.92%
SpS122.82
BVpS23.03
TBVpS3.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.74%
ROE -10.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.03%
FCFM N/A
ROA(3y)-5.45%
ROA(5y)-5.79%
ROE(3y)-11.19%
ROE(5y)-11.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.88%
GM growth 5Y3.23%
F-Score3
Asset Turnover2.47
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Debt/EBITDA 8.59
Cap/Depr 76.95%
Cap/Sales 2.09%
Interest Coverage N/A
Cash Conversion 138.26%
Profit Quality N/A
Current Ratio 1.8
Quick Ratio 1.23
Altman-Z 4.42
F-Score3
WACC6.87%
ROIC/WACCN/A
Cap/Depr(3y)87.99%
Cap/Depr(5y)151.24%
Cap/Sales(3y)2.78%
Cap/Sales(5y)3.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-289.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-32.61%
EPS Next Y42.87%
EPS Next 2Y65.3%
EPS Next 3Y56.58%
EPS Next 5Y53.17%
Revenue 1Y (TTM)27.21%
Revenue growth 3Y30.76%
Revenue growth 5Y27.59%
Sales Q2Q%28.04%
Revenue Next Year25.45%
Revenue Next 2Y23.21%
Revenue Next 3Y21.76%
Revenue Next 5Y18.25%
EBIT growth 1Y-376.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year306.71%
EBIT Next 3Y99.9%
EBIT Next 5Y67.93%
FCF growth 1Y75.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y525.56%
OCF growth 3Y23.87%
OCF growth 5YN/A